Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1998 1
1999 1
2002 1
2004 2
2006 1
2007 2
2008 2
2009 4
2011 2
2012 3
2013 4
2014 2
2015 1
2016 3
2017 9
2018 4
2019 6
2020 2
2021 2
2022 2
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
Analysis of Factors Contributing to Adverse Events and Evaluation of Their Impact on Prognosis in Metastatic Renal Cell Carcinoma Patients-Real-World Experience in a Single-Center Retrospective Study and Narrative Review.
Domański P, Piętak M, Staneta S, Fortuniak W, Kruczyk B, Kobiernik A, Bakuła P, Mydlak A, Demkow T, Sikora-Kupis B, Dumnicka P, Kucharz J. Domański P, et al. Among authors: demkow t. Medicina (Kaunas). 2024 Feb 26;60(3):398. doi: 10.3390/medicina60030398. Medicina (Kaunas). 2024. PMID: 38541124 Free PMC article. Review.
Adverse Events of Cabozantinib as a Potential Prognostic Factor in Metastatic Renal Cell Carcinoma Patients: Real-World Experience in a Single-Center Retrospective Study.
Domański P, Piętak M, Kruczyk B, Jarosińska J, Mydlak A, Demkow T, Darewicz M, Sikora-Kupis B, Dumnicka P, Kamzol W, Kucharz J. Domański P, et al. Among authors: demkow t. Biomedicines. 2024 Feb 9;12(2):413. doi: 10.3390/biomedicines12020413. Biomedicines. 2024. PMID: 38398014 Free PMC article.
Activity of cabozantinib in further line treatment of metastatic clear cell renal cell carcinoma. Real-world experience in a single-center retrospective study.
Domański P, Jarosińska J, Kruczyk B, Piętak M, Mydlak A, Demkow T, Kuncman Ł, Darewicz M, Sikora-Kupis B, Dumnicka P, Kucharz J. Domański P, et al. Among authors: demkow t. Contemp Oncol (Pozn). 2023;27(3):190-197. doi: 10.5114/wo.2023.133545. Epub 2023 Dec 7. Contemp Oncol (Pozn). 2023. PMID: 38239858 Free PMC article.
Simple yet (more?) effective. Venous thromboembolism risk assessment model for germ cell tumour patients receiving first-line chemotherapy.
Michalski W, Poniatowska G, Jońska-Gmyrek J, Żółciak-Siwińska A, Zastawna I, Lemiński A, Macios A, Jakubczyk M, Demkow T, Wiechno P. Michalski W, et al. Among authors: demkow t. Cancer Med. 2023 Sep;12(18):18542-18556. doi: 10.1002/cam4.6458. Epub 2023 Aug 16. Cancer Med. 2023. PMID: 37584231 Free PMC article.
Prognostic value of pan-immune-inflammation value and body mass index in geriatric patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors as first line treatment. A single-center retrospective study.
Domański P, Jarosińska J, Kruczyk B, Piętak M, Mydlak A, Demkow T, Kuncman Ł, Darewicz M, Sikora-Kupis B, Michalski W, Kucharz J. Domański P, et al. Among authors: demkow t. Contemp Oncol (Pozn). 2023;27(4):242-248. doi: 10.5114/wo.2023.134786. Epub 2024 Jan 30. Contemp Oncol (Pozn). 2023. PMID: 38405212 Free PMC article.
First experience in treating advanced urothelial cancer with enfortumab vedotin. Single-centre retrospective study of patients qualified for a rescue access procedure.
Sikora-Kupis B, Domański P, Fortuniak W, Kruczyk B, Staneta S, Piętak M, Mydlak A, Demkow T, Dumnicka P, Kucharz J. Sikora-Kupis B, et al. Among authors: demkow t. Contemp Oncol (Pozn). 2023;27(4):224-229. doi: 10.5114/wo.2023.134751. Epub 2024 Feb 10. Contemp Oncol (Pozn). 2023. PMID: 38405211 Free PMC article.
Mixed epithelial and stromal tumor of the kidney: A case report.
Kalinowski P, Kalinowski T, Kucharz J, Kamecki H, Adamowicz B, Sikora K, Podgórska J, Demkow T. Kalinowski P, et al. Among authors: demkow t. Oncol Lett. 2022 Nov 23;25(1):25. doi: 10.3892/ol.2022.13611. eCollection 2023 Jan. Oncol Lett. 2022. PMID: 36478902 Free PMC article.
58 results